Cargando…

Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany

Around 1% of the world’s population is infected with hepatitis C. The introduction of new direct-acting antiviral agents (DAAs) in 2014 has substantially improved hepatitis C treatment outcomes. Our objective was to evaluate the long-term cost effectiveness of DAAs in health care personnel (HP) with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Runge, Melanie, Krensel, Magdalene, Westermann, Claudia, Bindl, Dominik, Nagels, Klaus, Augustin, Matthias, Nienhaus, Albert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013637/ https://www.ncbi.nlm.nih.gov/pubmed/31936470 http://dx.doi.org/10.3390/ijerph17020440

Ejemplares similares

Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
por: Westermann, Claudia, et al.
Publicado: (2018)

Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
por: Westermann, Claudia, et al.
Publicado: (2021)

Hepatitis C among healthcare personnel: secondary data analyses of costs and trends for hepatitis C infections with occupational causes
por: Westermann, Claudia, et al.
Publicado: (2016)

Occupational Infections among Dental Health Workers in Germany—14-Year Time Trends
por: Malsam, Rebecca, et al.
Publicado: (2021)

COVID-19 as an Occupational Disease—Temporal Trends in the Number and Severity of Claims in Germany
por: Nienhaus, Albert, et al.
Publicado: (2023)

Cost of illness of non-multidrug-resistant tuberculosis in Germany: an update
por: Diel, Roland, et al.
Publicado: (2020)

The First Year of Noninvasive Remote Telemonitoring in Chronic Heart Failure Is not Cost Saving but Improves Quality of Life: The Randomized Controlled CardioBBEAT Trial
por: Völler, Heinz, et al.
Publicado: (2022)

Involvement of occupational physicians in the management of MRSA-colonised healthcare workers in Germany – a survey
por: Dulon, Madeleine, et al.
Publicado: (2013)

Long-Term Effects of COVID-19 on Workers in Health and Social Services in Germany
por: Peters, Claudia, et al.
Publicado: (2022)

Health behaviour, health status and occupational prospects of apprentice nurses and kindergarten teachers in Germany: a cross-sectional study
por: Wirth, Tanja, et al.
Publicado: (2016)

Musculoskeletal Complaints in Occupational Therapists Compared to the General Population: A Cross-Sectional Study in Germany
por: Zenker, Ronny, et al.
Publicado: (2020)

The Occupational Risk of Influenza A (H1N1) Infection among Healthcare Personnel during the 2009 Pandemic: A Systematic Review and Meta-Analysis of Observational Studies
por: Lietz, Janna, et al.
Publicado: (2016)

Cost of illness in inclusion body myositis: results from a cross-sectional study in Germany
por: Senn, Katja C., et al.
Publicado: (2023)

Long-acting antiviral agents for HIV treatment
por: Margolis, David A., et al.
Publicado: (2015)

Gesetzliches Hautkrebsscreening in Deutschland: Motivation und Motive zur Teilnahme versus Nichtteilnahme
por: Girbig, G., et al.
Publicado: (2021)

COVID-19 among Health Workers in Germany—An Update
por: Nienhaus, Albert
Publicado: (2021)

Infections in Healthcare Workers in Germany—22-Year Time Trends †
por: Nienhaus, Albert
Publicado: (2018)

COVID-19 among Health Workers in Germany and Malaysia
por: Nienhaus, Albert, et al.
Publicado: (2020)

Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study
por: Schablon, Anja, et al.
Publicado: (2010)

Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany
por: Schreiber-Katz, Olivia, et al.
Publicado: (2014)

Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
por: McGlynn, Elizabeth A., et al.
Publicado: (2019)

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents
por: Angeletti, Andrea, et al.
Publicado: (2019)

The Burden of COVID-19 in Health Workers
por: Nienhaus, Albert, et al.
Publicado: (2022)

Workplace Health Promotion and COVID-19 Support Measures in Outpatient Care Services in Germany: A Quantitative Study
por: Neumann, Felix Alexander, et al.
Publicado: (2021)

Occupational cancer in Germany.
por: Brüske-Hohlfeld, I
Publicado: (1999)

MRSA as an occupational disease: a case series
por: Haamann, Frank, et al.
Publicado: (2011)

The occupational risk of Helicobacter pylori infection among gastroenterologists and their assistants
por: Peters, Claudia, et al.
Publicado: (2011)

Hepatitis-Induced Porphyria: Are Direct-Acting Antiviral Agents the Way of the Future?
por: John, Jason J., et al.
Publicado: (2021)

IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
por: Wang, Yadong, et al.
Publicado: (2022)

Prevalence of CMV infection among staff in a metropolitan children’s hospital – occupational health screening findings
por: Stranzinger, Johanna, et al.
Publicado: (2016)

Consequences of tuberculosis among asylum seekers for health care workers in Germany
por: Diel, Roland, et al.
Publicado: (2016)

COVID-19 Vaccination: Status and Willingness to Be Vaccinated among Employees in Health and Welfare Care in Germany
por: Kozak, Agnessa, et al.
Publicado: (2021)

Seroconversion after needlestick injuries – analyses of statutory accident insurance claims in Germany
por: Dulon, Madeleine, et al.
Publicado: (2018)

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus
por: Kanda, Tatsuo, et al.
Publicado: (2015)

Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
por: Kanda, Tatsuo, et al.
Publicado: (2014)

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
por: La Manna, Gaetano
Publicado: (2018)

Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
por: Toshikuni, Nobuyuki
Publicado: (2017)

Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents
por: Ghweil, Ali A, et al.
Publicado: (2019)

Direct-Acting Antiviral Agents for HCV-Associated Glomerular Disease and the Current Evidence
por: Fabrizi, Fabrizio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i9e6tqihtjdktg0fnro6ug1t2f